AMID vs. HELX ETF Comparison

Comparison of Argent Mid Cap ETF (AMID) to Franklin Genomic Advancements ETF (HELX)
AMID

Argent Mid Cap ETF

AMID Description

AMID aims to outperform the Russell MidCap Index over the long term by applying Change-Based Investing strategies. The fund actively invests in stocks undergoing positive internal or external change, which the issuer believes could lead to underappreciated growth. The starting universe begins with 1,500 US mid-cap stocks that are screened for liquidity and grouped by sector. Using their proprietary Argent Alpha Model, stocks are ranked under four main categories: Value, Growth, Quality, and Stability. Stocks within each sector with positive exposure to outperforming factors are considered. The remaining companies are grouped into current and future market segments based on expected outperformance in the current or future market cycle. Finally, the fund uses fundamental analysis to select 35-50 stocks with prospect improvements at the company or industry level. Sectors may be overweighted at various times in the economic cycle. Individual securities are capped at 8%.

Grade (RS Rating)

Last Trade

$37.03

Average Daily Volume

7,912

Number of Holdings *

37

* may have additional holdings in another (foreign) market
HELX

Franklin Genomic Advancements ETF

HELX Description Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation

Grade (RS Rating)

Last Trade

$29.86

Average Daily Volume

2,835

Number of Holdings *

53

* may have additional holdings in another (foreign) market
Performance
Period AMID HELX
30 Days 5.95% -4.15%
60 Days 4.28% -8.40%
90 Days 5.77% -10.93%
12 Months 35.20% 7.62%
2 Overlapping Holdings
Symbol Grade Weight in AMID Weight in HELX Overlap
A D 2.12% 2.14% 2.12%
MEDP D 2.69% 3.87% 2.69%
AMID Overweight 35 Positions Relative to HELX
Symbol Grade Weight
FICO B 3.79%
CTAS B 3.66%
CPRT A 3.56%
BLDR D 3.43%
FTNT C 3.34%
HLI B 3.2%
CBZ B 2.93%
LPLA A 2.87%
CDW F 2.86%
VCTR B 2.86%
DHI D 2.85%
IT C 2.83%
MUSA A 2.63%
HCA F 2.49%
BAH F 2.45%
BLD D 2.43%
OMF A 2.4%
URI B 2.35%
AFG A 2.28%
GDDY A 2.24%
ADUS D 2.09%
CG A 2.05%
SCI B 2.05%
TPX B 1.99%
AME A 1.98%
ICFI F 1.93%
LNG B 1.69%
CHDN B 1.57%
ABG B 1.55%
ENTG D 1.52%
MOH F 1.44%
PATK D 1.35%
TTEK F 1.33%
AX A 1.11%
EXPO D 0.99%
AMID Underweight 51 Positions Relative to HELX
Symbol Grade Weight
NTRA B -6.07%
VRTX F -5.76%
KRYS B -4.71%
LLY F -4.49%
DHR F -4.09%
REGN F -4.09%
TMO F -4.0%
UTHR C -2.63%
CDNS B -2.52%
CTVA C -2.48%
AZN D -2.39%
INSM C -2.27%
BNTX D -2.24%
IONS F -2.07%
CRL C -2.04%
QGEN D -2.01%
RVTY F -1.96%
BRKR D -1.95%
ALNY D -1.93%
SRPT D -1.53%
RARE D -1.49%
EXAS D -1.32%
ICLR D -1.26%
LGND B -1.24%
TWST D -1.22%
RCKT F -1.22%
LH C -1.18%
RGEN D -1.06%
IQV D -1.03%
TECH D -0.98%
AZTA D -0.97%
NBIX C -0.96%
BEAM D -0.95%
BBIO F -0.89%
VYGR F -0.82%
VCYT B -0.61%
MRNA F -0.59%
RXRX F -0.58%
BIO D -0.55%
CDMO B -0.54%
DVAX C -0.5%
CRSP D -0.49%
DOCS C -0.46%
AVTR F -0.45%
NTLA F -0.42%
BMY B -0.37%
CRNX C -0.25%
BMRN D -0.2%
ARE D -0.15%
FDMT F -0.11%
SLP D -0.1%
Compare ETFs